Electromed Inc
Research Electromed Inc (ELMD) on Bullrun: valuation model: 7.7% undervalued, market cap USD 349.67M, P/E 36.3. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerELMD
- ExchangeNYSE MKT
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Valuation signal7.7% undervalued
- Market capUSD 349.67M
- P/E36.3
- Financial periodFY2025
- RevenueUSD 64.00M
- Revenue growth17.0%
- Net incomeUSD 7.54M
- Free cash flowUSD 11.13M
- Gross margin78.1%
Valuation Snapshot
Bullrun's latest valuation model marks Electromed Inc as 7.7% undervalued; latest market cap is USD 349.67M; P/E is 36.3.
About Electromed Inc
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally.
Frequently asked questions
Is Electromed Inc overvalued or undervalued?
Bullrun's valuation model currently marks Electromed Inc as 7.7% undervalued.
What is Electromed Inc's market cap?
Electromed Inc's market capitalization is USD 349.67M.
What is Electromed Inc's P/E ratio?
Electromed Inc's price-to-earnings (P/E) ratio is 36.3.
What does Electromed Inc do?
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally.